Physician

Constance L Scott, DO

According to 2025 Medicare claims, Constance Scott, DO (NPI: 1144331398) practices dermatology in the Saginaw, MI market, with the plurality of this provider's patient population coming from Saginaw, MI. This provider's primary affiliated billing organization is ALL SEASONS SKIN AND SURGERY CENTER (NPI: 1528323185) and primary practice location at 48603-2730.

Scott's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 611 traditional Medicare patients, billed 5,540 HCPCS/CPT codes, and received $168,690 in Medicare payments. The top billing code was 11104 (Punch biopsy, first skin growth). Part D data shows 3,230 prescription claims across 959 beneficiaries totaling $83,139 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 10 records totaling $134. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $280,581 to $168,690. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $228,447 to $83,139. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$140K$281K2015 Medicare payment: $280,581 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $264,327 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $232,088 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $224,479 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $267,283 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $213,560 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $217,683 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $194,934 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $174,569 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $168,690 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,0078,659$280,581
20161,0258,423$264,327
20179838,526$232,088
20188908,024$224,479
20198698,293$267,283
20207176,181$213,560
20216546,042$217,683
20225785,749$194,934
20235735,347$174,569
20246115,540$168,690

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$114K$228K2015 Drug cost: $228,447 (USD; Tot_Drug_Cst)2016 Drug cost: $176,902 (USD; Tot_Drug_Cst)2017 Drug cost: $159,693 (USD; Tot_Drug_Cst)2018 Drug cost: $127,598 (USD; Tot_Drug_Cst)2019 Drug cost: $115,271 (USD; Tot_Drug_Cst)2020 Drug cost: $94,622 (USD; Tot_Drug_Cst)2021 Drug cost: $95,002 (USD; Tot_Drug_Cst)2022 Drug cost: $97,136 (USD; Tot_Drug_Cst)2023 Drug cost: $97,607 (USD; Tot_Drug_Cst)2024 Drug cost: $83,139 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20158232,612$228,447
20169132,714$176,902
20179502,755$159,693
20188652,553$127,598
20198542,378$115,271
20207882,241$94,622
20219012,473$95,002
20227782,225$97,136
20238122,373$97,607
20249593,230$83,139

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11104Punch biopsy, first skin growth153175$72
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more127127$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more496755$54
17000Destruction of precancer skin growth, 1 growth310643$37
17003Destruction of precancer skin growth, 2-14 growths2762,584$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate43612,919$14,548
KetoconazoleKetoconazole67825,219$11,084
MetronidazoleMetronidazole1816,116$8,559
Ammonium LactateAmmonium Lactate48418,504$8,292
FluorouracilFluorouracil1374,058$6,839

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$134STRATA Skin Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Constance L. Scott, DO?

Tedicare shows public-source Medicare data for Constance L. Scott, DO (NPI 1144331398), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Constance L. Scott, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Constance L. Scott, DO?

Constance L. Scott, DO is linked to ALL SEASONS SKIN AND SURGERY CENTER (billing NPI 1528323185) in the available physician profile data.

Does Constance L. Scott, DO have Open Payments data?

Constance L. Scott, DO has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.